PART 01: EXECUTIVE SUMMARY PART 02: SCOPE OF THE REPORT PART 03: RESEARCH METHODOLOGY PART 04: MARKET LANDSCAPE • Market ecosystem • Market characteristics • Market segmentation analysis PART 05: MARKET SIZING • Market definition • Market sizing 2017 • Market size and forecast 2017-2022 PART 06: FIVE FORCES ANALYSIS • Bargaining power of buyers • Bargaining power of suppliers • Threat of new entrants • Threat of substitutes • Threat of rivalry • Market condition PART 07: CUSTOMER LANDSCAPE PART 08: MARKET SEGMENTATION BY APPLICATION • Segmentation by application • Comparison by application • Drug discovery outsourcing • Medical device manufacturing outsourcing • Market opportunity by application PART 09: REGIONAL LANDSCAPE • Geographical segmentation • Regional comparison • Americas • EMEA • APAC • Market opportunity PART 10: DECISION FRAMEWORK PART 11: DRIVERS AND CHALLENGES • Market drivers • Market challenges PART 12: MARKET TRENDS • Growth in number of M&A • Focus on promotional activities • Advances in technology PART 13: VENDOR LANDSCAPE • Overview • Landscape disruption PART 14: VENDOR ANALYSIS • Vendors covered • Vendor classification • Market positioning of vendors • Charles River • FLEX • Laboratory Corporation of America • Piramal Enterprises • Syneos Health • TE Connectivity PART 15: APPENDIX • List of abbreviations     Exhibit 01: Parent market Exhibit 02: Global healthcare market Exhibit 03: Market characteristics Exhibit 04: Market segments Exhibit 05: Market definition - Inclusions and exclusions checklist Exhibit 06: Market size 2017 Exhibit 07: Validation techniques employed for market sizing 2017 Exhibit 08: Global healthcare contract research and manufacturing outsourcing market 2017-2022 ($ bn) Exhibit 09: Global healthcare contract research and manufacturing outsourcing market– Year-over-year growth 2018-2022 (%) Exhibit 10: Five forces analysis 2017 Exhibit 11: Five forces analysis 2022 Exhibit 12: Bargaining power of buyers Exhibit 13: Bargaining power of suppliers Exhibit 14: Threat of new entrants Exhibit 15: Threat of substitutes Exhibit 16: Threat of rivalry Exhibit 17: Market condition - Five forces Exhibit 18: Customer landscape Exhibit 19: Application – Market share 2017-2022 (%) Exhibit 20: Comparison by application Exhibit 21: Drug discovery outsourcing – Market size and forecast 2017-2022 ($ bn) Exhibit 22: Drug discovery outsourcing– Year-over-year growth 2018-2022 (%) Exhibit 23: Medical devices manufacturing outsourcing– Market size and forecast 2017-2022 ($ bn) Exhibit 24: Medical devices manufacturing outsourcing– Year over year growth 2018-2022 (%) Exhibit 25: Market opportunity by application Exhibit 26: Global – Market share by geography 2017-2022 (%) Exhibit 27: Regional comparison Exhibit 28: Americas – Market size and forecast 2017-2022 ($ bn) Exhibit 29: Americas – Year over year growth 2018-2022 (%) Exhibit 30: Top three countries in Americas Exhibit 31: EMEA – Market size and forecast 2017-2022 ($ bn) Exhibit 32: EMEA – Year over year growth 2018-2022 (%) Exhibit 33: Top three countries in EMEA Exhibit 34: APAC – Market size and forecast 2017-2022 ($ bn) Exhibit 35: APAC – Year over year growth 2018-2022 (%) Exhibit 36: Top three countries in APAC Exhibit 37: Market opportunity Exhibit 38: R&D spending in US and Europe Exhibit 39: Vendor landscape Exhibit 40: Landscape disruption Exhibit 41: Vendors covered Exhibit 42: Vendor classification Exhibit 43: Market positioning of vendors Exhibit 44: Charles River overview Exhibit 45: Charles River– Business segments Exhibit 46: Charles River– Organizational developments Exhibit 47: Charles River– Geographic focus Exhibit 48: Charles River– Segment focus Exhibit 49: Charles River– Key offerings Exhibit 50: FLEX overview Exhibit 51: FLEX– Business segments Exhibit 52: FLEX– Organizational developments Exhibit 53: FLEX– Geographic focus Exhibit 54: FLEX– Segment focus Exhibit 55: FLEX– Key offerings Exhibit 56: Laboratory Corporation of America overview Exhibit 57: Laboratory Corporation of America– Business segments Exhibit 58: Laboratory Corporation of America– Organizational developments Exhibit 59: Laboratory Corporation of America– Geographic focus Exhibit 60: Laboratory Corporation of America– Segment focus Exhibit 61: Laboratory Corporation of America– Key offerings Exhibit 62: Piramal Enterprises overview Exhibit 63: Piramal Enterprises– Business segments Exhibit 64: Piramal Enterprises– Organizational developments Exhibit 65: Piramal Enterprises– Geographic focus Exhibit 66: Piramal Enterprises– Segment focus Exhibit 67: Piramal Enterprises– Key offerings Exhibit 68: Syneos Health overview Exhibit 69: Syneos Health– Business segments Exhibit 70: Syneos Health– Organizational developments Exhibit 71: Syneos Health– Geographic focus Exhibit 72: Syneos Health– Segment focus Exhibit 73: Syneos Health– Key offerings Exhibit 74: TE Connectivity overview Exhibit 75: TE Connectivity– Business segments Exhibit 76: TE Connectivity– Organizational developments Exhibit 77: TE Connectivity– Geographic focus Exhibit 78: TE Connectivity– Segment focus Exhibit 79: TE Connectivity– Key offerings

Charles River, FLEX, Laboratory Corporation of America, Piramal Enterprises, Syneos Health, TE Connectivity.